Poseida Therapeutics (PSTX)
(Delayed Data from NSDQ)
$2.08 USD
+0.06 (2.97%)
Updated Apr 22, 2024 11:48 AM ET
After-Market: $2.15 +0.07 (3.37%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.27 |
Last EPS Surprise | 25.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.77 |
Next Year | -1.92 |
EPS (TTM) | -1.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.25M | 11.25M | 45.00M | 20.00M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 15.00M | 15.00M | 60.00M | 30.00M |
Low Estimate | 7.50M | 7.50M | 30.00M | 10.00M |
Year ago Sales | 10.34M | 20.01M | 64.70M | 45.00M |
Year over Year Growth Est. | 8.80% | -43.78% | -30.45% | -55.56% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.44 | -1.77 | -1.92 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.40 | -0.41 | -1.56 | -1.64 |
High Estimate | -0.38 | -0.36 | -1.26 | -1.23 |
Low Estimate | -0.48 | -0.52 | -2.06 | -2.49 |
Year ago EPS | -0.45 | -0.32 | -1.37 | -1.77 |
Year over Year Growth Est. | 4.44% | -37.50% | -29.20% | -8.33% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 3 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.44 | -1.77 | -1.92 |
7 Days Ago | -0.43 | -0.44 | -1.77 | -1.92 |
30 Days Ago | -0.43 | -0.44 | -1.77 | -1.92 |
60 Days Ago | -0.34 | -0.36 | -1.61 | -1.94 |
90 Days Ago | -0.34 | -0.36 | -1.61 | -1.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.44 | -1.77 | -1.92 |
Zacks Consensus Estimate | -0.43 | -0.44 | -1.77 | -1.92 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.27 | -0.35 | -0.32 | -0.45 | NA |
Estimate | -0.36 | -0.29 | -0.53 | -0.40 | NA |
Difference | 0.09 | -0.06 | 0.21 | -0.05 | 0.05 |
Surprise | 25.00% | -20.69% | 39.62% | -12.50% | 7.86% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more